🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and courageous battle with the disease, we are deeply saddened to declare that D’Angelo, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and collaborations with high-profile artists.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album reached No. 4 on the R&B charts, went platinum soon after, and received several Grammy nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his artistic journey into the stratosphere. The album premiered at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the singer, famously stripped down to his midsection, performing straight into the lens.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the soul music rankings and a award for Best R&B Album.

Once more, in his own mysterious way, D’Angelo made only a few public outings in the subsequent period.

The singer was announced as a headliner for the 2025 music event, but his appearance was canceled, due to an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had apparently been hospitalized for an extended period and in hospice for two weeks.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the illness, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only provide dear memories with his family, but we are forever thankful for the legacy of extraordinarily moving songs he leaves behind,” his kin expressed.

Pancreatic Cancer: Lethal and Rarely Preventable

Pancreatic malignancy affects the pancreas, a tiny gland that generates insulin and is vital in breaking down food, among other functions. The size and location of the organ in the body make it more difficult to detect malignancy.

Even though pancreatic cancer accounts for only about 3% of malignancy cases each year in the United States, it is responsible for seven percent of cancer deaths.

Nearly 70,000 people will be diagnosed with pancreatic cancer and roughly 52,000 will die of the disease in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and dismal outcomes. We have limited and poor therapies, and a narrow opportunity to make a significant difference on the lives of people,” noted a cancer specialist.

Because this disease seldom produces initial signs, it’s frequently identified only once the disease is late-stage. Although a patient has indicators they are usually vague and may be mistaken for a several everyday ailments.

“As of yet, there is no effective method to detect this malignancy in the early stages, except for listening to your body and consulting your physician if there are unfamiliar symptoms,” explained a medical director.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five age bracket. However, many cancers, such as pancreatic cancer, have become increasingly prevalent among younger people.

“This disease identified before the age of 50 is deemed uncommon, yet concerningly, doctors are beginning to see a rising count of younger individuals suffering from this disease,” said a expert.

Genetic Background Affects Disease Probability

In the absence of reliable screening tools for this malignancy, professionals stressed the significance of understanding your relatives’ cancer history. Some risk factors, such as tobacco use and obesity also play a role in the onset of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward lowering one’s risk of this condition is assessing personal risk factors. Individuals should examine their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a specialist.

Hereditary risk factors are linked to as much as ten percent of all pancreatic cancer cases. If someone in your family has had this disease, you may want to think about genetic testing.

“For people with a relative’s background of pancreatic cancer or those having high risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Excessive drinking is linked to pancreatitis, a contributing element for this malignancy, so limiting or abstaining from drinks may help lower your chance.

Controlling your weight or shedding pounds may also aid reduce your risk. Individuals with obesity are twenty percent more prone to get this disease. This malignancy also is more frequent in those with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with therapies and newer combination chemotherapy. There are developing targeted therapies that are already showing results,” remarked a expert.

For many individuals, however, awareness about this rare but {dev